Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial
Authors
Faustino R. Pérez‐López (ORCID: https://orcid.org/0000-0002-2801-416X)
Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial
Faustino R. Pérez‐López, Wei Xiong, Yan Deng, Guo Ying-ying et al.
Journal
Therapeutic Advances in Endocrinology and Metabolism
Topics
Ovarian function and disorders
article
Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial
Faustino R. Pérez‐López, Wei Xiong, Yan Deng, Guo Ying-ying, Xuesong Ding, Wei Xue, Ruilin Ma, Yanfang Wang, Tao Tao, Yue Wang, Wang Weilu, Yang Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
Therapeutic Advances in Endocrinology and MetabolismVol. 16
Institutions
Beijing University of Chinese Medicine (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Universidad de Zaragoza (ES), Peking Union Medical College Hospital (CN), Instituto de Nanociencia y Materiales de Aragón (ES), Instituto de Investigación Sanitaria Aragón (ES), Qilu Hospital of Shandong University (CN)